With all eyes focused on the much anticipated end of the week offering of Alibaba, there are 6 additional companies quietly expecting to make their debuts this week:
Civitas Solutions, Inc. (CIVI:NYSE) is the leading national provider of home- and community-based health and human services to must-serve individuals with intellectual, developmental, physical or behavioral disabilities and other special needs. The company is offering 11.7M shares @ $20.00-23.00. The offering is led by Barclays, BAML, and UBS.
* Update: they priced 11.7M shares @ $17.00, well below the range.
Tokai Pharmaceuticals Inc. (TKAI:NSDQ) is a clinical-stage biopharmaceutical company focused on developing novel proprietary therapies for the treatment of prostate cancer and other hormonally-driven diseases. They are offering 5.4M shares @ $13-15. The offering is led by BMO Capital Markets, Stifel, and William Blair.
*Update: they priced an upsized 6.48M shares @ $15.00, the high end of the range.
rEVO Biologics, Inc. (RBIO: NSDQ) is a commercial-stage biopharmaceutical company focused on the development and commercialization of specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions. They are offering 3.6M shares @ $13.00-15.00. The offering is led by Piper Jaffray and Guggenheim Securities.
*Update: the offering has been postponed and may come some time next week.
Foamix Pharmaceuticals Ltd. (FOMX: NSDQ) is a clinical-stage specialty pharmaceutical company focused on developing and commercializing our proprietary minocycline foam for the treatment of acne, impetigo and other skin conditions. The company is offering 5.91M shares @ $10.00-12.00. The offering is led by Barclays and Cowen & Company.
ProQR Therapeutics B.V. (PRQR: NSDQ) is an innovative biopharmaceutical company engaged in the discovery and development of RNA-based therapeutics for the treatment of severe genetic disorders, with an initial focus on Cystic Fibrosis, or CF. They are offering 6.25M shares @ $11.00-13.00. The offering is led by Leerink Partners and Deutsche Bank.
Viking Therapeutics, Inc. (VKTX: NSDQ) is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders. They are offering 5M shares @ $10.00-12.00. The offering is being led by Oppenheimer & Co. and Roth Capital Partners.
Last but not least….
Alibaba Group Holding Limited (BABA: NYSE) is the largest online and mobile commerce company in the world in terms of gross merchandise volume in 2013, according to the IDC GMV Report. They operate their ecosystem as a platform for third parties, and they do not engage in direct sales, compete with their merchants or hold inventory. The company is offering 320M shares @ $60-66, which would be a market cap of approx $170B at the high end of the range. The offering is being led by Credit Suisse, Deutsche Bank, Goldman, JP Morgan, Morgan Stanley, and Citigroup.
*Update: Due to high demand, the range has been increased to $66-68.
SyndicateTrader 